Absci CorpNASDAQ:ABSI
- LAST PRICE4.6000
- TODAY'S CHANGE (%)0.1450 (3.2548%)
- Bid / Lots4.5900/ 8
- Ask / Lots4.6000/ 4
- Open / Previous Close4.5000 / 4.4550
- Day Range
- 52 Week Range
- Volume251,704
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ABSI |
|---|---|---|
| 09:32 ET | 10279 | 4.48 |
| 09:34 ET | 300 | 4.49 |
| 09:36 ET | 10630 | 4.48 |
| 09:38 ET | 1985 | 4.4999 |
| 09:39 ET | 3449 | 4.55 |
| 09:41 ET | 5352 | 4.58 |
| 09:43 ET | 5722 | 4.64 |
| 09:45 ET | 4398 | 4.61 |
| 09:48 ET | 12843 | 4.57 |
| 09:50 ET | 1740 | 4.55 |
| 09:52 ET | 6734 | 4.57 |
| 09:54 ET | 1643 | 4.55 |
| 09:56 ET | 2000 | 4.57 |
| 09:57 ET | 999 | 4.6 |
| 09:59 ET | 543 | 4.61 |
| 10:01 ET | 1703 | 4.6 |
| 10:03 ET | 3100 | 4.595 |
| 10:06 ET | 600 | 4.61 |
| 10:08 ET | 4414 | 4.59 |
| 10:10 ET | 100 | 4.59 |
| 10:12 ET | 4502 | 4.6 |
| 10:14 ET | 8458 | 4.62 |
| 10:15 ET | 1720 | 4.63 |
| 10:17 ET | 4880 | 4.68 |
| 10:19 ET | 18286 | 4.68 |
| 10:21 ET | 2918 | 4.63 |
| 10:24 ET | 2359 | 4.645 |
| 10:26 ET | 1684 | 4.65 |
| 10:28 ET | 1402 | 4.65 |
| 10:30 ET | 2100 | 4.66 |
| 10:32 ET | 958 | 4.66 |
| 10:33 ET | 644 | 4.675 |
| 10:35 ET | 3683 | 4.675 |
| 10:37 ET | 3372 | 4.64 |
| 10:39 ET | 1860 | 4.63 |
| 10:42 ET | 2089 | 4.6499 |
| 10:44 ET | 1550 | 4.64 |
| 10:46 ET | 3000 | 4.615 |
| 10:48 ET | 5500 | 4.605 |
| 10:50 ET | 841 | 4.6002 |
| 10:51 ET | 3923 | 4.59 |
| 10:53 ET | 1000 | 4.59 |
| 10:55 ET | 300 | 4.6 |
| 10:57 ET | 531 | 4.595 |
| 11:00 ET | 11358 | 4.63 |
| 11:02 ET | 1128 | 4.6425 |
| 11:04 ET | 3586 | 4.64 |
| 11:06 ET | 300 | 4.64 |
| 11:08 ET | 900 | 4.63 |
| 11:09 ET | 1400 | 4.62 |
| 11:11 ET | 4098 | 4.61 |
| 11:13 ET | 800 | 4.6 |
| 11:15 ET | 1500 | 4.59 |
| 11:18 ET | 3328 | 4.6 |
| 11:20 ET | 700 | 4.61 |
| 11:22 ET | 1101 | 4.59 |
| 11:24 ET | 1000 | 4.59 |
| 11:26 ET | 900 | 4.59 |
| 11:27 ET | 374 | 4.59 |
| 11:29 ET | 100 | 4.59 |
| 11:31 ET | 1100 | 4.585 |
| 11:33 ET | 300 | 4.585 |
| 11:36 ET | 2449 | 4.585 |
| 11:38 ET | 1526 | 4.585 |
| 11:40 ET | 974 | 4.595 |
| 11:44 ET | 1934 | 4.595 |
| 11:45 ET | 1292 | 4.6 |
| 11:47 ET | 514 | 4.595 |
| 11:49 ET | 300 | 4.6 |
| 11:51 ET | 300 | 4.6 |
| 11:54 ET | 300 | 4.595 |
| 11:56 ET | 400 | 4.6 |
| 11:58 ET | 300 | 4.595 |
| 12:00 ET | 712 | 4.59 |
| 12:02 ET | 6906 | 4.575 |
| 12:05 ET | 2235 | 4.59 |
| 12:07 ET | 925 | 4.61 |
| 12:09 ET | 100 | 4.605 |
| 12:12 ET | 823 | 4.615 |
| 12:14 ET | 500 | 4.61 |
| 12:16 ET | 406 | 4.61 |
| 12:18 ET | 2319 | 4.6 |
| 12:20 ET | 216 | 4.61 |
| 12:21 ET | 1248 | 4.6 |
| 12:23 ET | 200 | 4.6 |
| 12:25 ET | 300 | 4.6 |
Apr 16, 2024
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024, from 8:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:00AM ET on Tuesday Apr 16, 2024 by Dow Jones
Mar 28, 2024
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Absci Corp | 502.5M | -3.8x | --- |
Astria Therapeutics Inc | 503.5M | -3.9x | --- |
Altimmune Inc | 510.4M | -4.4x | --- |
Adlai Nortye Ltd | 496.7M | -7.9x | --- |
Applied Therapeutics Inc | 483.2M | -3.1x | --- |
Prime Medicine Inc | 515.7M | -2.0x | --- |
Company Information
Absci Corporation is a generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The Company uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The Company supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. It reconstructs prevalent immune-response molecules, such as antibodies from disease tissue and identify their corresponding antigens, offering new therapeutic targets.
Contact Information
- Headquarters
- 18105 Se Mill Plain BlvdVANCOUVER, WA, United States 98683
- Phone
- 360-949-1041
- Fax
- 302-655-5049
Executives
- Chief Executive Officer, Founder, Director
- Sean Mcclain
- Chief Financial Officer, Chief Business Officer, Treasurer
- Zachariah Jonasson
- Independent Director
- Andreas Busch
- Lead Independent Director
- Karen Mcginnis
- Director
- Frans Houten
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $502.5M |
|---|---|
Revenue (TTM) | $5.7M |
Shares Outstanding | 112.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.20 |
Book Value | $1.89 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | 87.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,020.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
